Trial Profile
Optimized Antiplatelet Therapy With Aspirin and Clopidogrel Improves Mortality Compared to Standard Treatment.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Mar 2013
Price :
$35
*
At a glance
- Drugs Aspirin (Primary) ; Clopidogrel (Primary) ; Antiplatelets
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Adverse reactions
- Acronyms BOCLA-Mort
- 25 Feb 2013 New trial record